Prevention magazine selected EndoPAT among top medical breakthroughs

EndoPAT Overview

 

EndoPAT is the leading medical device for noninvasive endothelial function assessment.It is FDA-cleared , CE-marked and used in preeminent clinical and research institutions, major epidemiological population based studies (such as Framingham Heart Study) and Pharmaceutical clinical phase studies in over 40 countries with thousands of tests performed every month.

Endothelial Dysfunction- The Risk of the Risk Factors

For more than a decade Endothelial Dysfunction has been recognized by the medical community as the critical junction between risk factors and clinical disease. It is the earliest detectable stage of cardiovascular disease. Furthermore, it is treatable, and unlike the atherosclerotic plaque which it causes, is even reversible. The EndoPAT adds an important dimension to cardiovascular prevention by enabling physicians to reliably measure endothelial function and identify pathological cases of endothelial dysfunction at early stages.

Read more about the EndoPAT in its product overview

EndoPAT Major Features and Advantages

  • FDA cleared and CE marked
  • Reliable and reproducible results
  • Noninvasive
  • User independent
  • Easy to use
  • Office-based
  • Supports both clinical and research applications
  • Contra-lateral arm monitors systemic changes